MAR vs VRTV: Which Is the Better Buy?

Side-by-side comparison of Marriott International, Inc. and Veritiv Corporation β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-19.
Marriott International, Inc. Β· Consumer Cyclical
$334.97
+20.6% upside to fair value
Med Conviction Grade C
VS
Veritiv Corporation Β· Industrials
$169.99
-45.0% upside to fair value
Med Conviction Grade D
QuantHub Verdict
MAR has more upside to fair value (+20.6%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric MAR VRTV
Current Price $334.97 $169.99
Fair Value Estimate $403.81 $93.49
Upside to Fair Value +20.6% -45.0%
Market Cap $87.3B $2.3B
Forward P/E β€” β€”
EV / EBITDA 22.2x 5.4x
Price / Sales 3.2x 0.4x
Price / FCF 28.7x 10.4x
Revenue Growth YoY +4.8% -19.0%
Gross Margin 20.2% 22.7%
Operating Margin 15.8% 5.9%
Return on Equity -66.7% 48.6%
Dividend Yield 0.84% 1.48%
FCF Yield 3.48% 9.57%
Analyst Consensus Hold Hold
Investment Thesis
MAR β€” Marriott International, Inc.
Marriott International is a global asset-light hotel franchisor and manager whose 10,082-property, 1.814 million-room system, 629,000-room development pipeline, broad brands, and more than 295 million Bonvoy members support durable fee-led economics. Business quality is tempered by cyclicality, competitive owner incentives, and $16.915 billion of debt, while reported ROE is negative 66.7%. In the…
VRTV β€” Veritiv Corporation
Veritiv Corporation is a business-to-business distributor of specialty packaging, facility solutions, print, and publishing products, operating through four segments with a network of distribution centers and roughly 5,000 employees. The business quality is mixed: it generates a strong 48.6% ROE and trades at a low 7.13 trailing P/E and 5.44 EV/EBITDA, but revenue declined 19.0% year over year in…
Accumulation Zones
Metric MAR VRTV
Zone Low $302.86 $70.12
Zone High $343.24 $79.47
In Buy Zone? Yes No
← MAR Research    VRTV Research β†’    All Research